Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
RVMD
RVMD News & Events
-
Add to Watchlist
Trade RVMD Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
RVMD News
Revolution Medicines Achieves Strong Phase 3 Clinical Trial Results
2d ago
NASDAQ.COM
Revolution Medicines Stock Soars 285% Amid Clinical Progress
2d ago
Fool
Biotech Firms Shift to Nanotechnology-Driven Drug Delivery
4d ago
Globenewswire
Biotech Companies Focus on Drug Delivery Technologies
4d ago
Newsfilter
Investors Eye Economic Data and Earnings Reports
6d ago
stocktwits
Revolution Medicines Reports Phase 3 Results for Daraxonrasib
Jun 01 2026
NASDAQ.COM
Daraxonrasib Significantly Improves Pancreatic Cancer Survival Rates
Jun 01 2026
stocktwits
Revolution Medicines' Cancer Drug Trial Shows Promising Results
May 31 2026
seekingalpha
Show More News
RVMD Events
No data
RVMD Monitor News
Revolution Medicines Reports Positive Daraxonrasib Trial Results
Jun 02 2026
Revolution Medicines Reports Breakthrough Results for Daraxonrasib
Jun 01 2026
Revolution Medicines Inc. reaches 20-day high amid strong market gains
May 20 2026
Revolution Medicines stock declines amid market weakness
May 15 2026
Revolution Medicines Reports Positive Trial Results for Daraxonrasib
May 07 2026
Revolution Medicines Gains Attention for Breakthrough Cancer Therapy
May 04 2026
Revolution Medicines Reports Positive Clinical Data for Daraxonrasib
Apr 28 2026
Revolution Medicines Reports Updated Clinical Data for Zoldonrasib
Apr 23 2026
Show More Monitor News
RVMD Earnings Analysis
Revolution Medicines Earnings: Strategic Growth Q3 2025- Intellectia AI™
7 months ago
People Also Watch
